HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
暂无分享,去创建一个
K. Rye | L. Curtiss | L. Kritharides | J. Burnett | W. Jessup | M. Eck | A. Kontush | C. Quinn | M. Van Eck | W. Le Goff | M. Chapman | J. Chapman | M. Kockx | Liming Hou | S. Wales | S. Cartland | K. R | Mi-Jurng Kim | Australia | M. K. | Xian-Ming Du | Mi‐Jurng Kim
[1] P. Barter,et al. Cardioprotective functions of HDLs1 , 2014, Journal of Lipid Research.
[2] A. Nègre-Salvayre,et al. Small, Dense High-Density Lipoprotein-3 Particles Are Enriched in Negatively Charged Phospholipids: Relevance to Cellular Cholesterol Efflux, Antioxidative, Antithrombotic, Anti-Inflammatory, and Antiapoptotic Functionalities , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[3] R. D'Agostino,et al. High-density lipoproteins: a consensus statement from the National Lipid Association. , 2013, Journal of clinical lipidology.
[4] A. Leis,et al. Novel Formulation of a Reconstituted High-Density Lipoprotein (CSL112) Dramatically Enhances ABCA1-Dependent Cholesterol Efflux , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[5] Robert L Wilensky,et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. , 2011, The New England journal of medicine.
[6] L. Curtiss,et al. Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma , 2010, Nature Structural &Molecular Biology.
[7] A. Khera,et al. Future Therapeutic Directions in Reverse Cholesterol Transport , 2010, Current atherosclerosis reports.
[8] K. Gaus,et al. Expression and stability of two isoforms of ABCG1 in human vascular cells. , 2010, Atherosclerosis.
[9] P. Giral,et al. Stimulation of Cholesterol Efflux by LXR Agonists in Cholesterol-Loaded Human Macrophages Is ABCA1-Dependent but ABCG1-Independent , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[10] G. Franceschini,et al. Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1. , 2009, Biochemistry.
[11] K. Gaus,et al. Cyclosporin A Decreases Apolipoprotein E Secretion from Human Macrophages via a Protein Phosphatase 2B-dependent and ATP-binding Cassette Transporter A1 (ABCA1)-independent Pathway* , 2009, The Journal of Biological Chemistry.
[12] Gordon H Guyatt,et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis , 2009, BMJ : British Medical Journal.
[13] A. Vaughan,et al. ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation ** This work was supported by National Institutes of Health Grant RO1HL-55362. Published, JLR Papers in Press, September 5, 2008. , 2009, Journal of Lipid Research.
[14] A. Vaughan,et al. Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux* , 2009, Journal of Lipid Research.
[15] I. Gelissen,et al. Coexistence of Foam Cells and Hypocholesterolemia in Mice Lacking the ABC Transporters A1 and G1 , 2008, Circulation research.
[16] P. Barter,et al. New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease , 2007, Current cardiology reports.
[17] K. Gaus,et al. Secretion of Apolipoprotein E From Macrophages Occurs via a Protein Kinase A– and Calcium-Dependent Pathway Along the Microtubule Network , 2007, Circulation research.
[18] D. Rader,et al. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. , 2007, The Journal of clinical investigation.
[19] Amy B. Ghering,et al. ABCA1-Induced Cell Surface Binding Sites for ApoA-I , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[20] P. Barter,et al. Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E Published, JLR Papers in Press, February 1, 2006. , 2006, Journal of Lipid Research.
[21] M. Hayden,et al. Macrophage ATP-Binding Cassette Transporter A1 Overexpression Inhibits Atherosclerotic Lesion Progression in Low-Density Lipoprotein Receptor Knockout Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[22] E. Tuzcu,et al. Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano. , 2006, Journal of the American College of Cardiology.
[23] A. Kontush,et al. Antiatherogenic small, dense HDL—guardian angel of the arterial wall? , 2006, Nature Clinical Practice Cardiovascular Medicine.
[24] I. Gelissen,et al. ABCA1 and ABCG1 Synergize to Mediate Cholesterol Export to ApoA-I , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[25] J. Heinecke,et al. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. , 2005, Physiological reviews.
[26] A. Vaughan,et al. ABCG1 Redistributes Cell Cholesterol to Domains Removable by High Density Lipoprotein but Not by Lipid-depleted Apolipoproteins* , 2005, Journal of Biological Chemistry.
[27] G. Halliday,et al. Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD/E site in vitro. , 2005, Biochemistry.
[28] Paul T. Tarr,et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. , 2005, Cell metabolism.
[29] G. Anantharamaiah,et al. Influence of ApoA-I Structure on the ABCA1-mediated Efflux of Cellular Lipids* , 2004, Journal of Biological Chemistry.
[30] A. Tall,et al. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[31] R. Dean,et al. Apolipoprotein A-I-stimulated Apolipoprotein E Secretion from Human Macrophages Is Independent of Cholesterol Efflux* , 2004, Journal of Biological Chemistry.
[32] A. Kontush,et al. Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[33] M. Reilly,et al. Overexpression of Apolipoprotein A-I Promotes Reverse Transport of Cholesterol From Macrophages to Feces In Vivo , 2003, Circulation.
[34] P. Barter,et al. Apolipoprotein A-II Inhibits High Density Lipoprotein Remodeling and Lipid-poor Apolipoprotein A-I Formation* , 2003, Journal of Biological Chemistry.
[35] S. Yokoyama,et al. Effects of Mutations of ABCA1 in the First Extracellular Domain on Subcellular Trafficking and ATP Binding/Hydrolysis* 210 , 2003, The Journal of Biological Chemistry.
[36] E. Favari,et al. Cellular cholesterol flux studies: methodological considerations. , 2002, Atherosclerosis.
[37] W. J. Johnson,et al. Effects of Enrichment of Fibroblasts with Unesterified Cholesterol on the Efflux of Cellular Lipids to Apolipoprotein A-I* , 2002, The Journal of Biological Chemistry.
[38] A. Horwitz,et al. Stably transfected ABCA1 antisense cell line has decreased ABCA1 mRNA and cAMP-induced cholesterol efflux to apolipoprotein AI and HDL. , 2001, Biochimica et biophysica acta.
[39] R. Dean,et al. A kinetic model to evaluate cholesterol efflux from THP-1 macrophages to apolipoprotein A-1. , 2001, Biochemistry.
[40] Y. Marcel,et al. Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL. , 2001, Journal of lipid research.
[41] R. Lawn,et al. ABCA1 Is the cAMP-inducible Apolipoprotein Receptor That Mediates Cholesterol Secretion from Macrophages* , 2000, The Journal of Biological Chemistry.
[42] J. Mcneish,et al. The Correlation of ATP-binding Cassette 1 mRNA Levels with Cholesterol Efflux from Various Cell Lines* , 2000, The Journal of Biological Chemistry.
[43] M. Krieger,et al. Binding of High Density Lipoprotein (HDL) and Discoidal Reconstituted HDL to the HDL Receptor Scavenger Receptor Class B Type I* , 2000, Journal of Biological Chemistry.
[44] K. Rye,et al. The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study. , 2000, Biochemistry.
[45] C. Gabel,et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[46] K. Rye,et al. Formation of Spherical, Reconstituted High Density Lipoproteins Containing Both Apolipoproteins A-I and A-II Is Mediated by Lecithin:Cholesterol Acyltransferase* , 2000, The Journal of Biological Chemistry.
[47] H. Brewer,et al. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[48] R. Dean,et al. Sterol Efflux Is Impaired from Macrophage Foam Cells Selectively Enriched with 7-Ketocholesterol* , 1996, The Journal of Biological Chemistry.
[49] G. Francis,et al. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. , 1995, The Journal of clinical investigation.
[50] R. Dean,et al. Apolipoprotein A-I-mediated efflux of sterols from oxidized LDL-loaded macrophages. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[51] J. Eugui,et al. Immunoturbidimetry of serum apolipoproteins A-I and B on the Cobas Bio centrifugal analyzer: method validation and reference values. , 1994, Clinical biochemistry.
[52] P. Barter,et al. The influence of apolipoproteins on the structure and function of spheroidal, reconstituted high density lipoproteins. , 1994, The Journal of biological chemistry.
[53] R. Stocker,et al. Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence. , 1994, Methods in enzymology.
[54] R. Dean,et al. A method for defining the stages of low-density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC. , 1993, Analytical biochemistry.
[55] R. Krauss,et al. Production of polyacrylamide gradient gels for the electrophoretic resolution of lipoproteins. , 1992, Journal of lipid research.
[56] A. Jonas,et al. Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins. , 1990, The Journal of biological chemistry.
[57] P. Weisweiler. Isolation and quantitation of apolipoproteins A-I and A-II from human high-density lipoproteins by fast-protein liquid chromatography. , 1987, Clinica chimica acta; international journal of clinical chemistry.
[58] J. C. Osborne. Delipidation of plasma lipoproteins. , 1986, Methods in enzymology.
[59] A. Jonas,et al. Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. , 1982, The Journal of biological chemistry.
[60] S. Goldstein,et al. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. , 1981, Journal of lipid research.
[61] M. Takayama,et al. A new enzymatic method for determination of serum choline-containing phospholipids. , 1977, Clinica chimica acta; international journal of clinical chemistry.